CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- 4 Grant or award President and CEO acquired 12,681 shares (grant or award)
- 4 Open-market buy Director bought 10,000 shares at $1.41 ($14,100)
- 4 Grant or award President and CEO acquired 10,802 shares (grant or award)
- 4/A Grant or award President and CEO acquired 10,736 shares (grant or award)
- 4 Grant or award President and CEO acquired 10,736 shares (grant or award)
- 4 Grant or award President and CEO acquired 9,777 shares (grant or award)
- 4 Grant or award President and CEO acquired 9,211 shares (grant or award)
- 4 Grant or award President and CEO acquired 8,028 shares (grant or award)
- 4/A Open-market sale 10% owner sold 10,000 shares at $2.09 ($20,870)
- 4 Open-market sale 10% owner sold 10,000 shares at $2.09 ($20,870)
- 4/A Grant or award President and CEO acquired 7,743 shares (grant or award)
- 4 Grant or award President and CEO acquired 10,606 shares (grant or award)
- 4 Open-market buy Director bought 5,000 shares at $2.50 ($12,500)
- 4 Grant or award President and CEO acquired 10,606 shares (grant or award)
- 4 Grant or award President and CEO acquired 13,359 shares (grant or award)
- 4 Grant or award President and CEO acquired 13,780 shares (grant or award)
- 4 Grant or award President and CEO acquired 13,566 shares (grant or award)
- 4 Open-market buy Director bought 5,000 shares at $1.33 ($6,650)
- 4 Grant or award President and CEO acquired 12,868 shares (grant or award)
- 4 Grant or award President and CEO acquired 11,290 shares (grant or award)
Page 9 of 39 · 776 filings